Axcelead Drug Discovery Partners is an integrated solutions provider in drug discovery and non-clinical research.
We established in 2017 as a spin-out company of Takeda Pharmaceuticals, and inherited Takeda’s drug discovery and non-clinical research capabilities, such as “Experienced Pharma Scientists”, “Cutting-edge Technology Platform”, and “Huge Legacy Data”.
Our scientists provide solutions to various issues at every stage of drug discovery based on their deep knowledge and extensive experience in drug discovery and non-clinical research across a broad range of therapeutic areas and biological target classes.
Moreover, Axcelead’s integrated drug discovery service covers target identification, hit identification, lead generation/optimization, and non-clinical pharmacology/DMPK/safety studies to identify a promising clinical candidate.